Public Profile

Bracco

Bracco Imaging S.p.A., commonly known as Bracco, is a leading global player in the medical imaging industry, headquartered in Italy. Founded in 1927, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. Bracco is renowned for its innovative contrast agents and advanced imaging solutions, which enhance diagnostic accuracy and patient care. With a commitment to research and development, Bracco has achieved significant milestones, including the introduction of groundbreaking products that set industry standards. Their core offerings, such as ultrasound contrast agents and MRI contrast media, are distinguished by their safety profiles and efficacy. As a trusted partner in healthcare, Bracco continues to solidify its market position through strategic collaborations and a focus on quality, making it a preferred choice among healthcare professionals worldwide.

DitchCarbon Score

How does Bracco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Bracco's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

14%

Let us know if this data was useful to you

Bracco's reported carbon emissions

In 2023, Bracco did not disclose specific carbon emissions data, making it challenging to assess their current environmental impact. However, in 2021, the company reported total emissions of approximately 72,373,000 kg CO2e, which included 21,033,000 kg CO2e from Scope 1 and 51,340,000 kg CO2e from Scope 2 emissions. This indicates a significant reliance on energy consumption and direct emissions from operations. Bracco has not set specific reduction targets or disclosed any climate pledges, which may limit their accountability in addressing climate change. The absence of detailed emissions data for 2022 and 2023 suggests a need for improved transparency in their sustainability reporting. Overall, while Bracco has made strides in emissions reporting in previous years, the lack of recent data and defined reduction initiatives raises questions about their commitment to climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021
Scope 1
49,469,000
00,000,000
00,000,000
00,000,000
Scope 2
41,475,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bracco's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Bracco is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Bracco is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Varian

US
Fabricated metal products, except machinery and equipment (28)
Updated about 9 hours ago

Boston Scientific

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 9 hours ago

Analogic Corporation

US
Medical, precision and optical instruments, watches and clocks (33)
Updated about 9 hours ago

Covidien plc

IE
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago
DitchCarbon Score

Guerbet

FR
Medical, precision and optical instruments, watches and clocks (33)
Updated about 9 hours ago

Lantheus Holdings, Inc.

US
Health and social work services (85)
Updated about 9 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers